Valuation : GI Innovation, Inc.

Market Cap 551B 411M 354M 335M 304M 570M 39.27B 573M 3.98B 1.53B 19.98B 1.54B 1.51B 63.13B P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 516B 385M 332M 314M 285M 534M 36.8B 537M 3.73B 1.44B 18.72B 1.45B 1.41B 59.16B EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.28%
Yield 2024 *
-
Yield 2025 -
1 day+3.52%
1 week+5.56%
Current month+4.40%
1 month-8.37%
3 months-38.21%
6 months-35.45%
Current year-51.59%
1 week 7,800
Extreme 7800
8,880
1 month 7,510
Extreme 7510
9,350
Current year 6,470
Extreme 6470
18,830
1 year 6,470
Extreme 6470
21,000
3 years 6,470
Extreme 6470
24,900
5 years 6,470
Extreme 6470
24,900
10 years 6,470
Extreme 6470
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 54 16/06/2021
Director/Board Member 58 01/07/2017
Director/Board Member 64 01/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/1/26 Expiration 14 0.0000% -
20/1/26 Exercice

Chief Technology Officer

445 0.0007%
20/1/26 Exercice 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+3.52%+5.56%-55.10%-33.61% 411M
-0.71%-6.35%-4.87%+9.03% 45.48B
+0.21%-2.98%+340.68%+519.93% 43.69B
+1.74%-2.24%+37.28%+21.57% 43.09B
+1.38%-3.28%+3.23%+65.60% 39.4B
-1.44%-5.26%+8.78%+36.85% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+18.07%+110.32% 16.4B
-0.31%-2.78%+10.47%+30.49% 14.24B
+1.93%-3.55%+74.20%+39.37% 13.28B
Average +0.79%-3.48%+48.08%+88.84% 26.52B
Weighted average by Cap. +0.42%-3.66%+72.95%+123.31%

Financials

2024 2025
Net sales 24.28M 18.11K 15.61K 14.78K 13.39K 25.13K 1.73M 25.26K 176K 67.49K 880K 68.03K 66.54K 2.78M 5.84B 4.36M 3.75M 3.55M 3.22M 6.04M 416M 6.07M 42.2M 16.23M 212M 16.36M 16M 669M
Net income -58.78B -43.85M -37.78M -35.78M -32.43M -60.84M -4.19B -61.15M -425M -163M -2.13B -165M -161M -6.74B -35.13B -26.21M -22.58M -21.38M -19.38M -36.36M -2.5B -36.55M -254M -97.66M -1.27B -98.44M -96.28M -4.03B
Net Debt -3.44B -2.57M -2.21M -2.09M -1.9M -3.56M -245M -3.58M -24.86M -9.56M -125M -9.64M -9.43M -394M -34.63B -25.83M -22.26M -21.07M -19.1M -35.84M -2.47B -36.02M -250M -96.25M -1.26B -97.02M -94.89M -3.97B
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
11/09/26 KRW 8,540.00 +3.52% 341,657
10/09/26 KRW 8,250.00 -2.60% 419,827
09/09/26 KRW 8,470.00 +0.59% 290,414
08/09/26 KRW 8,420.00 -3.99% 272,951
07/09/26 KRW 8,770.00 +8.41% 402,268
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!